Aterian Investment Partners Appoints Mark Lecher as New CEO of Allentown
Aterian Investment Partners, a prominent private equity firm, made headlines recently with the announcement of Mark Lecher's promotion to Chief Executive Officer (CEO) of Allentown, LLC. This strategic move marks a pivotal moment for the company, which specializes in vivarium solutions for the biomedical research community. Mark's impressive career spans over three decades, bringing a wealth of experience in various leadership roles within multiple multinational corporations. Throughout his tenure, he has proven himself as an effective leader, demonstrating an ability to adapt and thrive in dynamic environments.
Prior to ascending to the role of CEO, Mark Lecher served as Allentown's Chief Financial Officer (CFO). His tenure in this position was marked by significant contributions that not only enhanced the company's financial performance but also established a strong foundation for future growth. Under his guidance, Allentown has navigated a series of strategic acquisitions and operational enhancements, leading to an expanded product offering that positions the company as a leader in its industry.
John Coiro, the CEO Emeritus and a board member of Allentown, expressed his confidence in Mark's leadership capabilities. He stated, "Mark has made a substantial impact on our organization during his time as CFO. His collaborative engagement style and operational expertise set the stage for a new era of growth as he takes the helm as CEO. I am excited about the direction Allentown will take under Mark’s leadership." Coiro also highlighted the recent launch of the Discovery™ IVC smart cage as a testament to Allentown's commitment to innovation.
Mark shared his own thoughts on this exciting new chapter in his career, stating, "It is a great honor to serve as CEO of Allentown. Our company has established itself as the North American leader in vivarium solutions, and I am dedicated to advancing our mission of serving the global biomedical research community. With over 50 years of operational history and an expanding product portfolio, I look forward to collaborating with both the team at Allentown and Aterian to build a truly world-class organization."
Brandon Bethea, Co-Founder and Partner at Aterian, expressed their enthusiasm regarding Mark’s promotion. He noted that while Mark’s achievements as an executive are impressive, what stands out is his respect for the legacy established by the Coiro family over more than fifty-six years. Mark’s ability to build upon this legacy promises to enhance Allentown’s already strong connections with top-tier research institutions around the globe.
Allentown, founded in 1968, has transitioned from a localized manufacturer of animal housing solutions to an industry leader that caters to a global clientele that includes academic institutions, pharmaceuticals, contract research organizations, and government agencies. With its recent advancements and Mark at the helm, the company is poised to continue its trajectory of growth and success.
In summary, Aterian Investment Partners’ decision to promote Mark Lecher to CEO represents a significant step forward for Allentown as it prepares for future challenges and opportunities in the ever-evolving landscape of biomedical research. With its ongoing commitment to innovation and excellence, Allentown remains dedicated to providing cutting-edge solutions to the vivarium industry, ensuring it remains at the forefront of research and development in the years to come.
Prior to ascending to the role of CEO, Mark Lecher served as Allentown's Chief Financial Officer (CFO). His tenure in this position was marked by significant contributions that not only enhanced the company's financial performance but also established a strong foundation for future growth. Under his guidance, Allentown has navigated a series of strategic acquisitions and operational enhancements, leading to an expanded product offering that positions the company as a leader in its industry.
John Coiro, the CEO Emeritus and a board member of Allentown, expressed his confidence in Mark's leadership capabilities. He stated, "Mark has made a substantial impact on our organization during his time as CFO. His collaborative engagement style and operational expertise set the stage for a new era of growth as he takes the helm as CEO. I am excited about the direction Allentown will take under Mark’s leadership." Coiro also highlighted the recent launch of the Discovery™ IVC smart cage as a testament to Allentown's commitment to innovation.
Mark shared his own thoughts on this exciting new chapter in his career, stating, "It is a great honor to serve as CEO of Allentown. Our company has established itself as the North American leader in vivarium solutions, and I am dedicated to advancing our mission of serving the global biomedical research community. With over 50 years of operational history and an expanding product portfolio, I look forward to collaborating with both the team at Allentown and Aterian to build a truly world-class organization."
Brandon Bethea, Co-Founder and Partner at Aterian, expressed their enthusiasm regarding Mark’s promotion. He noted that while Mark’s achievements as an executive are impressive, what stands out is his respect for the legacy established by the Coiro family over more than fifty-six years. Mark’s ability to build upon this legacy promises to enhance Allentown’s already strong connections with top-tier research institutions around the globe.
Allentown, founded in 1968, has transitioned from a localized manufacturer of animal housing solutions to an industry leader that caters to a global clientele that includes academic institutions, pharmaceuticals, contract research organizations, and government agencies. With its recent advancements and Mark at the helm, the company is poised to continue its trajectory of growth and success.
In summary, Aterian Investment Partners’ decision to promote Mark Lecher to CEO represents a significant step forward for Allentown as it prepares for future challenges and opportunities in the ever-evolving landscape of biomedical research. With its ongoing commitment to innovation and excellence, Allentown remains dedicated to providing cutting-edge solutions to the vivarium industry, ensuring it remains at the forefront of research and development in the years to come.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.